September 2026
The AI-driven drug discovery platforms market is growing as pharmaceutical companies leverage AI to accelerate target identification and lead optimization.
September 2026
The global large molecule drug discovery outsourcing market size was evaluated at USD 3.49 billion in 2026 and is predicted to hit around USD 7.67 billion by 2035, growing at a CAGR of 9.14%.
September 2026
The artificial intelligence (AI) in drug discovery market size is predicted to surpass around USD 17.81 billion by 2035 from USD 7.62 billion in 2026 with a solid CAGR of 9.90%.
September 2026
The generative AI in drug discovery market size reached USD 331.91 million in 2026 and is estimated to hit around USD 2,724.15 million by 2035, at a CAGR of 26.45%.
September 2026
The global drug discovery outsourcing market size was valued at USD 4.78 billion in 2026 and is projected to hit around USD 8.98 billion by 2035 with a CAGR of 7.27%.
September 2026
The global drug discovery market size was evaluated at USD 78.51 billion in 2026 and is projected to hit around USD 171.36 billion by 2035 with a CAGR of 9.07%.
September 2026
The drug discovery services market size was estimated at USD 27.89 billion in 2026 and is expected to hit around USD 89.58 billion by 2035, growing at a CAGR of 13.95% from 2026 to 2035.
September 2026
The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.83 billion in 2026, with a CAGR of 9.70%.
September 2026
The computational medicine and drug discovery software market size reached USD 12.94 billion in 2026, with leading computational medicine and drug discovery software market companies including Entelos Inc., Crown Bioscience Inc., Chemical Computing Group Inc., Nimbus Therapeutics Inc.
September 2026
The U.S. drug discovery market generated USD 28.66 billion in 2026, with prominent U.S. drug discovery market companies including Johnson and Johnson, Pfizer Inc., Merck and Co.
September 2026
The CNS drug discovery market was valued at USD 10.86 billion in 2026, with leading companies including Eli Lilly and Company, Roche, Novartis, Pfizer, AbbVie.
September 2026
The drug discovery informatics market size stood at USD 5.35 billion in 2026, with major drug discovery informatics companies including collaborative drug discovery inc, eurofins discoverx products, jubilant biosys, selvita, novo informatics pvt ltd.
July 2026
The global in-silico drug discovery market size is estimated to hit around USD 11.8 billion by 2035 increasing from USD 4.17 billion in 2025, with a CAGR of 10.96%.
March 2026
The global computer-aided drug discovery market size is projevted to hit around USD 14.38 billion by 2035 from USD 4.72 billion in 2025 with a CAGR of 11.78%.
January 2026
The global small molecule drug discovery market size is calculated at USD 95.63 billion in 2025 and is projected to hit around USD 204.06 billion by 2035 with a CAGR of 7.87%.
September 2026
The pharma 4.0 market was valued at USD 23.16 billion in 2026, with leading companies including Matthews Specialty Vehicles, Farber Specialty Vehicles, Medical Coaches.
September 2026
The quantum computing in healthcare market was valued at USD 414.14 million in 2026, with leading companies including IBM, Microsoft, Google.
September 2026
The fetal bovine serum market was valued at USD 2.73 billion in 2026, with leading companies including TCS Biosciences Ltd, Merck KGaA, Gemini Bio-Products.
September 2026
The global generic drugs market size is estimated at USD 491.67 billion in 2026 and is projected to reach USD 762.48 billion by 2035 at a 5% CAGR, driven by rising demand for affordable medicines and patent-expired drugs.
September 2026
The psoriatic arthritis therapeutics drugs market is growing with rising demand for biologics, biosimilars, and advanced targeted treatment options.
September 2026
The gig economy tech platforms market is growing as digital platforms connect freelancers, businesses, and on-demand workers worldwide.
September 2026
The uterine fibroid drugs market reached USD 3.61 billion in 2026, featuring leading uterine fibroid drugs market companies such as AbbVie Inc., Pfizer Inc., Bayer AG, Takeda Pharmaceutical Company Limited.
September 2026
The contraceptive drugs and devices market size reached USD 35.23 billion in 2026 and is projected to surpass around USD 58.87 billion by 2035, with a notable CAGR of 5.88%.
September 2026
The global anthelmintic drugs market size was evaluated at USD 4.4 billion in 2026 and is predicted to hit around USD 9.01 billion by 2035, growing at a CAGR of 8.30%.
September 2026
The global performance enhancing drugs market size was evaluated at USD 468.43 million in 2026 and is predicted to hit around USD 892.09 million by 2035, growing at a CAGR of 7.42%.
September 2026
The global general anesthesia drugs market size was calculated at USD 5.81 billion in 2026 and is projected to surpass around USD 8.06 billion by 2035, with a CAGR of 3.71%.
September 2026
The global critical care drugs market size was evaluated at USD 1.28 billion in 2026 and is projected to surge around USD 2.00 billion by 2035, with a CAGR of 5.07%.
September 2026
The multiexperience development platforms market size reached USD 6.34 billion in 2026, with leading multiexperience development platforms market companies including Appian Corporation, Cigniti Technologies.
September 2026
The global AI-driven lab automation market driven by increasing need for efficiency, reduced manual errors, and advanced AI systems enhancing lab productivity.
September 2026
The global expectorant drugs market size was evaluated at USD 19.56 billion in 2026 and is predicted to hit around USD 29.72 billion by 2035, growing at a CAGR of 4.76%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com